299 related articles for article (PubMed ID: 1627187)
1. In vitro antifungal activity of sertaconazole.
Drouhet E; Dupont B
Arzneimittelforschung; 1992 May; 42(5A):705-10. PubMed ID: 1627187
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of sertaconazole.
Palacín C; Sacristán A; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):699-705. PubMed ID: 1627186
[TBL] [Abstract][Full Text] [Related]
3. In vitro comparative study of the fungistatic and fungicidal activity of sertaconazole and other antifungals against Candida albicans.
Palacín C; Sacristán A; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):711-4. PubMed ID: 1627188
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ergosterol synthesis by sertaconazole in Candida albicans.
Agut J; Palacín C; Sacristán A; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):718-20. PubMed ID: 1627190
[TBL] [Abstract][Full Text] [Related]
5. Direct membrane-damaging effect of sertaconazole on Candida albicans as a mechanism of its fungicidal activity.
Agut J; Palacín C; Salgado J; Casas E; Sacristán A; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):721-4. PubMed ID: 1627191
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimycotic activity of (benzo[b]thienyl)methyl ethers of 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-ethanol and of (Z)-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone oxime.
Raga MM; Moreno-Mañas M; Cuberes MR; Palacín C; Castelló JM; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):691-4. PubMed ID: 1627184
[TBL] [Abstract][Full Text] [Related]
7. Antifungal activity of sertaconazole in vitro against clinical isolates of Candida spp.
Martin-Mazuelos E; Aller AI; Morilla D; Montero O
Chemotherapy; 1996; 42(2):112-7. PubMed ID: 8697886
[TBL] [Abstract][Full Text] [Related]
8. In-vitro antifungal activity of sertaconazole, econazole, and bifonazole against Candida spp.
Carrillo-Muñoz AJ; Torres-Rodriguez JM
J Antimicrob Chemother; 1995 Oct; 36(4):713-6. PubMed ID: 8591947
[TBL] [Abstract][Full Text] [Related]
9. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
Croxtall JD; Plosker GL
Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
[TBL] [Abstract][Full Text] [Related]
10. Study on the sensitizing capacity of the new antimycotic sertaconazole in the treatment of cutaneous mycoses.
Romaguera C; Herrero E; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):754-6. PubMed ID: 1627200
[TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis.
Carrillo-Muñoz AJ; Guglietta A; Palacín C; Casals J; del Valle O; Guardià C; Rodríguez V; Quindós G
Chemotherapy; 2004 Dec; 50(6):308-13. PubMed ID: 15608448
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of antifungal activity of sertaconazole, terbinafine, and bifonazole against clinical isolates of Candida spp., Cryptococcus neoformans and dermatophytes.
Carillo-Muñoz AJ; Tur-Tur C
Chemotherapy; 1997; 43(6):387-92. PubMed ID: 9395851
[TBL] [Abstract][Full Text] [Related]
13. In vitro antifungal activity of N-3-(1,2,4-dithiazole-5-thione)-beta-resorcylcarbothioamide.
Niewiadomy A; Krajewska-Kułak E; Lukaszuk C; Matysiak J; Kostecka M
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():31-5. PubMed ID: 16119621
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of cutaneous dermatophytosis.
Pedragosa R; González B; Martín M; Herrero E; Roset P; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):760-3. PubMed ID: 1627202
[TBL] [Abstract][Full Text] [Related]
15. Antifungal agents. III. Naphthyl and thienyl derivatives of 1H-imidazol-1-yl-4-phenyl-1H-pyrrol-3-ylmethane.
Massa S; Di Santo R; Costi R; Simonetti G; Retico A; Apuzzo G; Artico M
Farmaco; 1993 Jun; 48(6):725-36. PubMed ID: 8373500
[TBL] [Abstract][Full Text] [Related]
16. [The comparison of susceptibility of Candida albicans and Candida glabrata to miconazole].
Kurnatowski P; Makieło L; Horwatt-Bozyczko E
Wiad Parazytol; 2001; 47(4):867-73. PubMed ID: 16886440
[TBL] [Abstract][Full Text] [Related]
17. Multi-centre double-blind trial on the efficacy and safety of sertaconazole 2% cream in comparison with miconazole 2% cream on patients suffering from cutaneous mycoses.
Alomar C; Bassas S; Casas M; Crespo V; Ferrándiz C; Fonseca E; Hernández B; Noguera J; Pedragosa R; Peyrí J
Arzneimittelforschung; 1992 May; 42(5A):767-73. PubMed ID: 1627204
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of the therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of superficial mycoses caused by Candida albicans.
Umbert P; Nasarre J; Bello A; Herrero E; Roset P; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):757-60. PubMed ID: 1627201
[TBL] [Abstract][Full Text] [Related]
19. In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole.
Wei GX; Bobek LA
J Antimicrob Chemother; 2004 May; 53(5):750-8. PubMed ID: 15073161
[TBL] [Abstract][Full Text] [Related]
20. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM
Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
